VCP ScannerFree US Stock Screener & Financial AnalysisFree US Stock Screener
ScreenerThemes
DCF ValuationCalculate intrinsic value of US stocks
Market ValuationBuffett indicator, CAPE & macro gauges
Total ReturnSee dividends + price return history
DCA CalculatorSimulate recurring buys & compounding
Earnings
FAANG & Tech
AAPL vs MSFTNVDA vs AMDGOOGL vs META
Cloud & Cyber
CRM vs NOWCRWD vs PANWSNOW vs DDOG
Consumer & Auto
TSLA vs FAMZN vs WMTNFLX vs DIS
Finance & Crypto
JPM vs BACV vs MACOIN vs MSTR
Pharma & Energy
LLY vs NVOJNJ vs PFEXOM vs CVX
Compare Any Stocks...
WatchlistInsider
ScreenerThemes
Earnings
WatchlistInsider
SIGA
← Back to Screener
VCP ScannerFree US Stock Screener & Financial Analysis

Find stocks. Verify deeply. Act with conviction.

Data updated daily

Product

  • Screener
  • Themes
  • Valuation
  • Total Return
  • DCA Calculator
  • News
  • Earnings

Resources

  • Market Valuation
  • Compare
  • Insider Activity
  • Methodology
  • How It Works
  • Glossary
  • Learn

Get Ideas

Get weekly stock ideas — free

© 2026 VCP Scanner
AboutPrivacyTerms
Not financial advice. Do your own research.
ScreenerNewsCompareWatchlist
SIGASIGA Technologies, Inc.
$3.61$259M
Overview & Verdict
Overview
Valuation & Forecasts
Valuation ModelsEstimatesDCF Model
Price & Analyst Data
Analyst TargetsPrice HistoryTechnical Analysis
Financial Statements
Income StatementBalance SheetCash FlowRatios & Margins
Performance
P/E HistoryRevenue HistoryEarnings HistoryDividend HistoryTotal Return
Ownership
Holders
HomeStocksSIGAFinancials

SIGA Technologies, Inc. (SIGA) Financials

30Y historyFree accessUpdated daily

Revenue volatility remains acute, evidenced by a 95.3% year-over-year decline in 2025Q4 and gross margins that swung from 97.8% in 2025Q1 to 21.2% in 2025Q4.

SIGA Income Statement

Income StatementBalance SheetCash FlowRatios
AnnualQuarterly
MetricTTMDec'25Dec'24Dec'23Dec'22Dec'21Dec'20Dec'19Dec'18Dec'17Dec'16Dec'15Dec'14Dec'13Dec'12Dec'11Dec'10Dec'09Dec'08Dec'07Dec'06Dec'05Dec'04Dec'03Dec'02Dec'01Dec'00Dec'99Dec'98Dec'97Dec'96
Sales/Revenue93.78M94.6M138.72M139.92M110.78M133.67M124.96M26.74M477.05M12.27M14.99M8.18M3.14M5.52M8.97M12.73M19.22M13.81M8.07M6.7M7.26M8.48M1.84M731.74K344.45K1.16M483.12K500K500K700K100K
Revenue Growth %-22.06%-31.8%-0.86%26.31%-17.13%6.97%367.28%-94.39%3788.3%-18.14%83.32%160.39%-43.11%-38.48%-29.51%-33.77%39.13%71.24%20.41%-7.7%-14.38%360.9%151.34%112.44%-70.29%140%-3.38%0%-28.57%600%-
Cost of Goods Sold32.49M29.7M31.29M17.83M10.43M16.6M25.74M15.09M108.29M16.68M19.71M13.13M10.83M13.86M18.21M00000000000-945.4K-400K-200K00
COGS % of Revenue-31.4%22.56%12.74%9.42%12.42%20.6%56.41%22.7%135.95%131.51%160.6%344.93%251.06%203.03%------------195.69%-80%-40%--
Gross Profit61.29M64.87M107.43M122.09M100.34M117.07M99.22M11.66M368.77M-4.41M-4.72M-4.95M-7.69M-8.34M-9.24M12.73M19.22M13.81M8.07M6.7M7.26M8.48M1.84M731.74K344.45K1.16M1.43M900K700K700K100K
Gross Margin %65.35%68.57%77.44%87.26%90.58%87.58%79.4%43.59%77.3%-35.95%-31.51%-60.6%-244.93%-151.06%-103.03%100%100%100%100%100%100%100%100%100%100%100%295.69%180%140%100%100%
Gross Profit Growth %--39.62%-12.01%21.67%-14.29%17.99%751.25%-96.84%8460.67%6.61%4.67%35.57%7.76%9.79%-172.63%-33.77%39.13%71.24%20.41%-7.7%-14.38%360.9%151.34%112.44%-70.29%-18.83%58.72%28.57%0%600%-
Operating Expenses40.65M41.17M37.45M38.47M57.64M27.98M14.72M13.98M13.67M13.21M14.62M11.59M13.51M14.67M13.29M44.11M31.94M25.69M16.8M14.16M14.07M11.01M10.72M6.03M3.71M4.42M8.51M4.4M5.9M3M1.5M
OpEx % of Revenue-43.52%26.99%27.5%52.04%20.93%11.78%52.27%2.87%107.69%97.57%141.77%430.32%265.72%148.19%346.6%166.21%186.01%208.32%211.41%193.84%129.87%582.82%823.6%1076.95%381.31%1761.89%880%1180%428.57%1500%
Selling, General & Admin4.67T3.13M25.14M22.04M35.12M18.03M14.72M13.25M12.88M12.3M13.71M10.58M12.52M13.24M11.41M25.74M9.28M8.27M5.19M4.22M4.92M2.71M4.44M2.95M1.94M2.57M4.96M2.3M2.8M2M800K
SG&A % of Revenue-3.31%18.12%15.75%31.7%13.49%11.78%49.56%2.7%100.28%91.5%129.43%398.86%239.97%127.19%202.27%48.29%59.86%64.34%62.99%67.77%32.01%241.14%402.75%564.14%221.72%1026.19%460%560%285.71%800%
Research & Development2.7T6.53M12.31M16.43M22.53M9.94M0013.02M16.68M19.71M13.13M10.83M13.86M18.21M18.37M22.66M17.42M11.61M9.94M9.15M8.3M4.17M2.94M1.77M1.73M2.61M1.7M2.9M900K700K
R&D % of Revenue-6.9%8.87%11.74%20.33%7.44%--2.73%135.95%131.51%160.6%344.93%251.06%203.03%144.33%117.92%126.15%143.98%148.42%126.07%97.86%226.51%402.16%512.81%149.48%540.01%340%580%128.57%700%
Other Operating Expenses031.51M00000726.11K78.94M16.79K-1.66M42.2K1.06K1.5K52200000002.12M136.75K0117.26K945.4K400K200K100K0
Operating Income20.64M23.7M69.98M83.62M42.7M89.09M84.5M-2.32M355.1M-18.85M-31.01M-30.95M-209.67M-23.52M-22.54M-31.38M-12.72M-11.88M-8.74M-7.46M-6.81M-2.53M-9.45M-5.29M-3.37M-3.26M-7.08M-3.5M-5.2M-2.3M-1.4M
Operating Margin %22%25.05%50.45%59.76%38.55%66.65%67.62%-8.68%74.44%-153.63%-206.94%-378.59%-6677.64%-426.07%-251.21%-246.6%-66.21%-86.01%-108.32%-111.41%-93.84%-29.87%-513.72%-723.6%-976.95%-281.31%-1466.21%-700%-1040%-328.57%-1400%
Operating Income Growth %--66.13%-16.31%95.83%-52.07%5.43%3738.91%-100.65%1983.9%39.23%-0.2%85.24%-791.59%-4.35%28.19%-146.66%-7.1%-35.96%-17.07%-9.58%-168.94%73.2%-78.44%-57.35%-3.17%53.95%-102.39%32.69%-126.09%-64.29%-
EBITDA21.07M24.26M70.52M84.16M43.22M89.62M85.03M-1.8M355.17M-18.72M-30.84M-30.71M-209.32M-23.05M-22.12M-30.81M-12.1M-11.4M-8.28M-6.21M-5.25M-1.2M-8.39M-4.56M-3.05M-2.7M-6.14M-3.1M-5M-2.2M-500K
EBITDA Margin %22.46%25.65%50.84%60.15%39.01%67.04%68.05%-6.71%74.45%-152.56%-205.77%-375.57%-6666.45%-417.68%-246.54%-242.13%-62.95%-82.57%-102.62%-92.77%-72.41%-14.21%-456.4%-622.53%-884.91%-233.29%-1270.52%-620%-1000%-314.29%-500%
EBITDA Growth %-62.95%-65.6%-16.2%94.73%-51.77%5.39%4836.69%-100.51%1997.58%39.31%-0.44%85.33%-807.97%-4.24%28.22%-154.72%-6.08%-37.78%-33.2%-18.26%-336.1%85.64%-84.27%-49.45%-12.68%55.93%-98%38%-127.27%-340%-
D&A (Non-Cash Add-back)430.73K562.61K538.42K538.29K517.64K522.37K529.81K527K69.63K132.19K174.28K247.36K351.56K463.14K419.36K568.29K625.34K475.09K459.88K1.25M1.56M1.33M1.05M739.56K317.03K556.86K945.4K400K200K100K900K
EBIT24.1M23.7M69.98M83.62M42.7M89.09M76.53M5.59M427.12M-23.57M-25.62M-38.72M-211.48M-23.59M-22.2M-6.93M-28.2M-11.88M-8.74M-7.46M-6.81M-2.53M-8.88M-5.29M-3.37M-3.26M-7.08M-3.48M-5.2M-1.8M-1.4M
Net Interest Income4.41M6.68M0000-3.02M-15.77M-15.48M-14.76M-14.06M-266.73K-455.81K-1.21M-172.99K0000000018.26K34.06K-192.68K-550.46K0000
Interest Income4.41M6.68M00000000000000000000018.26K34.06K000000
Interest Expense0000003.02M15.77M15.48M14.76M14.06M266.73K455.81K1.21M172.99K0000000000192.68K550.46K0000
Other Income/Expense6.29M6.7M6.09M4.16M1.43M218.94K-10.99M-7.86M56.54M-19.48M-8.67M-8.04M-2.27M-1.28M632.04K8.94M-37.45M-5.74M137.53K1.82M-3.09M244.79K74.97K-136.75K0-392.37K-155.59K0-1.3M0-900K
Pretax Income26.93M30.4M76.07M87.78M44.13M89.31M73.51M-10.18M411.64M-38.33M-39.68M-38.99M-211.93M-24.8M-22.37M-22.44M-19.4M-17.62B-8.6M-5.64M-9.9M-2.29M-12.06M-5.43M0-3.65M-7.24M0-6.5M0-2.3M
Pretax Margin %28.71%32.14%54.84%62.73%39.84%66.81%58.83%-38.06%86.29%-312.41%-264.78%-476.88%-6749.87%-449.26%-249.39%-176.31%-100.96%-127556.62%-106.62%-84.17%-136.39%-26.99%-655.72%-742.29%--315.15%-1498.41%--1300%--2300%
Income Tax6.67M7.1M16.86M19.71M10.23M19.86M17.17M-2.94M-10.17M-2.09M13.88K461.98K53.53M-7.62M-7.84M-36.03M15.47M5.74M0000493.36K-18.26K-34.06K467.79K706.05K100K1.4M-100K0
Effective Tax Rate %24.78%23.36%22.16%22.45%23.18%22.24%23.35%28.86%-2.47%5.46%-0.03%-1.18%-25.26%30.72%35.06%160.59%-79.76%-0.03%0%0%0%0%-4.09%0.34%--12.8%-9.75%--21.54%-0%
Net Income20.26M23.3M59.21M68.07M33.9M69.45M56.34M-7.24M421.81M-36.24M-39.7M-39.45M-265.46M-17.18M-14.53M13.59M-28.2M-17.62M-8.6M-5.64M-9.9M-2.29M-9.37M-5.28M-3.33M-3.73M-7.79M-3.6M-6.6M-2.2M-2.3M
Net Margin %21.61%24.63%42.69%48.65%30.61%51.96%45.09%-27.08%88.42%-295.34%-264.87%-482.53%-8454.68%-311.22%-161.95%106.82%-146.73%-127.56%-106.62%-84.17%-136.39%-26.99%-509.65%-721.11%-967.06%-321.66%-1612.35%-720%-1320%-314.29%-2300%
Net Income Growth %-58.25%-60.65%-13.01%100.76%-51.18%23.27%878.08%-101.72%1264.07%8.72%-0.63%85.14%-1445.43%-18.23%-206.87%148.21%-60.04%-104.87%-52.51%43.04%-332.72%75.6%-77.64%-58.41%10.69%52.12%-116.38%45.45%-200%4.35%-
Net Income (Continuing)20.25M23.3M59.21M68.07M33.9M69.45M56.34M-7.24M421.81M-36.24M-39.7M-39.45M-265.46M-17.18M-14.53M13.59M-28.2M-17.62M-8.6M-5.64M-9.9M-2.29M-9.37M-5.28M-3.33M-3.73M-7.79M-3.6M-6.6M-2.2M-2.3M
Discontinued Operations0000000000000000000000000000000
Minority Interest0000000000000000000000000000000
EPS (Diluted)0.280.330.830.950.460.910.71-0.095.10-0.46-0.69-0.73-4.97-0.33-0.280.09-0.62-0.47-0.25-0.17-0.35-0.09-0.40-0.34-0.32-0.44-1.08-0.55-1.01-0.57-0.75
EPS Growth %-59.26%-60.24%-12.63%106.52%-49.45%28.17%905.9%-101.73%1208.7%33.33%5.48%85.31%-1406.06%-17.86%-411.11%114.52%-31.91%-88%-47.06%51.43%-280.02%76.98%-17.65%-6.25%27.27%59.26%-96.36%45.54%-77.19%24%-
EPS (Basic)-0.330.830.950.460.920.71-0.095.28-0.46-0.69-0.73-4.97-0.33-0.280.57-0.62-0.47-0.25-0.17-0.35-0.09-0.40-0.34-0.32-0.44-1.08-0.55-1.01-0.57-0.75
Diluted Shares Outstanding71.65M71.6M71.77M71.68M73.55M76.4M79.44M82.18M82.71M78.87M57.19M53.78M53.42M52.37M51.64M54.06M45.15M37.46M34.73M33.33M28.2M24.82M23.72M15.72M10.45M8.5M7.2M6.59M6.55M3.89M3.07M
Basic Shares Outstanding71.65M71.6M71.25M71.36M72.93M75.32M79.26M81.03M79.92M78.77M57.19M53.78M53.41M52.05M51.64M50.93M45.15M37.46M34.73M33.33M28.2M24.82M23.72M15.72M10.45M8.5M7.2M6.58M6.54M3.89M3.07M
Dividend Payout Ratio-185.05%72.05%47.21%97.16%--------------------------

Key Metrics

Growth RegimeContracting
ProfitabilityStrained
Balance SheetFortress
Cash FlowMixed
Top Statement Risk

Lumpy government procurement dependency

Verified Source

Metrics are mathematically derived from official filings.

SEC 10-K (2026Q1)

Revenue Volatility Reflects Procurement Cycles

As reported in the company's recent financial filings, SIGA's revenue has experienced significant contraction, highlighted by a 95.3% year-over-year decline in 2025Q4, which underscores the inherent instability of a business model reliant on episodic, large-scale government contract deliveries rather than consistent, recurring commercial demand.

The dramatic fluctuations in quarterly revenue suggest that the company's top-line performance is dictated by the timing of BARDA delivery milestones rather than organic market growth. Investors should monitor whether the current revenue trough represents a structural decline or merely a temporary gap between major government replenishment cycles.

Gross Margin Sensitivity to Mix

Based on the provided income statement data, gross margins have demonstrated extreme volatility, swinging from a high of 97.8% in 2025Q1 to a low of 21.2% in 2025Q4, indicating that the company's profitability is highly sensitive to the specific product mix and contract pricing of each delivery.

This margin instability suggests that the company lacks the pricing power or cost structure consistency of a diversified pharmaceutical firm. The wide variance in gross margins warrants further investigation into whether recent cost pressures are indicative of rising manufacturing expenses or unfavorable changes in government contract terms.

Operating Leverage Remains Highly Unstable

According to the historical income statement data, SIGA's operating leverage is currently strained, as evidenced by the shift from a 70.1% operating margin in 2024Q4 to a negative 85.2% in 2026Q1, reflecting an inability to scale operating expenses efficiently during periods of low revenue recognition.

The company's cost structure appears to be relatively fixed, which causes significant operating losses when revenue fails to meet specific thresholds. This suggests that without a consistent pipeline of government orders, the current overhead may be unsustainable, potentially leading to further margin compression in future quarters.

Single Product Dependency Risks Sustainability

As indicated by the financial statements, the company's near-total reliance on TPOXX for revenue generation creates a precarious risk profile, where the absence of diversified income streams leaves the bottom line vulnerable to any shift in federal biodefense priorities or the expiration of sole-source procurement status.

Short-sellers may focus on the fact that the company's recent net losses, such as the $5.4 million loss in 2025Q4, highlight the danger of a single-product business model. The lack of a secondary commercial pipeline suggests that the company may struggle to maintain profitability if government demand for smallpox countermeasures continues to moderate.

SIGA — Frequently Asked Questions

Quick answers to the most common questions about buying SIGA stock.

What was SIGA Technologies, Inc.'s (SIGA) revenue in 2025?

For fiscal year 2025, SIGA Technologies, Inc. (SIGA) reported total revenue of $94.6M. This represents a 94500.0% increase compared to $0.1M in 1996.

Is SIGA Technologies, Inc. (SIGA) profitable?

SIGA Technologies, Inc. (SIGA) is profitable, generating $23.3M in net income for the fiscal year ending 2025 with a net profit margin of 24.6%.

What is SIGA Technologies, Inc.'s operating profit margin?

SIGA Technologies, Inc. (SIGA) reported an operating income of $23.7M, resulting in an operating profit margin of 25.1%. This margin reflects the operational efficiency of the business before interest and taxes.

What is SIGA Technologies, Inc.'s gross profit and gross margin?

SIGA Technologies, Inc. (SIGA) generated $64.9M in gross profit for the year, representing a gross profit margin of 68.6%. This demonstrates the company's core pricing power and production efficiency.